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Abstract
Heparin acetyl-CoA:alpha-glucosaminide N-acetyltransferase (N-acetyltransferase, EC 2.3.1.78) is an integral lysosomal
membrane protein containing 11 transmembrane domains, encoded by the HGSNAT gene. Deficiencies of N-acetyl-
transferase lead to mucopolysaccharidosis IIIC. We demonstrate that contrary to a previous report, the N-acetyltransferase
signal peptide is co-translationally cleaved and that this event is required for its intracellular transport to the lysosome.
While we confirm that the N-acetyltransferase precursor polypeptide is processed in the lysosome into a small amino-
terminal alpha- and a larger ß- chain, we further characterize this event by identifying the mature amino-terminus of each
chain. We also demonstrate this processing step(s) is not, as previously reported, needed to produce a functional
transferase, i.e., the precursor is active. We next optimize the biochemical assay procedure so that it remains linear as N-
acetyltransferase is purified or protein-extracts containing N-acetyltransferase are diluted, by the inclusion of negatively
charged lipids. We then use this assay to demonstrate that the purified single N-acetyltransferase protein is both necessary
and sufficient to express transferase activity, and that N-acetyltransferase functions as a monomer. Finally, the kinetic
mechanism of action of purified N-acetyltransferase was evaluated and found to be a random sequential mechanism
involving the formation of a ternary complex with its two substrates; i.e., N-acetyltransferase does not operate through a
ping-pong mechanism as previously reported. We confirm this conclusion by demonstrating experimentally that no
acetylated enzyme intermediate is formed during the reaction.
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Introduction
Mucopolysaccharidosis (MPS) IIIC (MIM: 252930), first
described by Kresse et al. in 1978 [1], is an autosomal recessive
disorder characterized by the lysosomal storage of heparin and
heparan sulfate fragments containing terminal non-reducing
alpha-glucosamine residues (alpha-GlcNH2). Clinically, MPS IIIC
is similar to the other three forms of MPS III (A, B & D). MPS III
has an occurrence of 1 in 66,000 births, with the IIIC form
accounting for 1 in 1,407,000 (MPS Society of Australia, http://
www.mpssociety.org.au/table_of_diseases.htm). Symptoms can
vary in their severity, including severe central nervous system
involvement, but only mild somatic manifestations [2]. Death
usually occurs in the late teens. The defective enzyme is heparin
acetyl-CoA: alpha-glucosaminide N-acetyltransferase, EC 2.3.1.78
(N-acetyltransferase) [3]. The gene encoding N-acetyltransferase,
HGSNAT, was only identified in 2006 by us [4] and others [5].
Since then 61 mutations in the HGSNAT gene have been identified
in MPS IIIC patients, 26 of which were missense [6,7].
Understanding the biosynthesis and processing events leading to
a functional N-acetyltransferase protein in lysosomes, as well as
determining if the development of enzymatic activity is dependent
on the oligomerization of the protein with itself and/or other gene
products, as previously reported [8,9], is essential for evaluating
the potential effectiveness of therapeutic approaches for MPS IIIC,
e.g., small molecule enzyme enhancement therapy [10].
N-acetyltransferase is an integral membrane protein whose
function is to acetylate the non-reducing, terminal alpha-GlcNH2
of intra-lysosomal fragments of heparin or heparan sulfate,
converting it into a substrate for luminal alpha -N-acetyl
glucosaminidase. However, it can also acetylate the ß-glucosamine
residues of artificial substrates [11], which is the basis for the
coupled (with ß-hexosaminidase) assay that is generally used for
this transferase (see methods). Therefore, N-acetyltransferase
catalyzes the only synthetic reaction known to occur in the
lysosome. To accomplish this reaction, the enzyme uses a second
cytosolic substrate, acetyl-coenzyme A (acetyl-CoA) [3]. Thus, the
two substrates are separated by the lysosomal membrane. The
mechanism by which N-acetyltransferase overcomes this spatial
problem is controversial. The most accepted model is the ping-
pong (double displacement) mechanism involving an initial
acetylation reaction of the enzyme forming a covalently modified
enzyme intermediate, E9, in the cytosol, followed by the transfer of
the acetyl group to the intra-lysosomal heparin-a-glucosamine
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operates via a random-order ternary-complex mechanism where
there is no preset order to the binding of the two substrates [14];
i.e., there is no release of an initial product (CoA), nor production
of a E9, prior to binding the second substrate (GlcNH2) and
generation of the final product (N-acetylglucosamine).
The deduced primary sequence of human N-acetyltransferase
predicts a 635 amino acid protein containing a 30 amino acid
amino-terminal (N-terminal) signal peptide, which, despite the
presence of a computer-predicted signal peptide cleavage site
between Gly30 and Arg31, has recently been reported to be non-
cleavable [13], and 11 other transmembrane domains (TMDs).
This degree of hydrophobicity partially explains why the enzyme
has been so difficult to purify by conventional means (Fig. 1A).
The number of TMDs suggests an orientation for the protein in
which its small N-terminal tail (present only if the signal peptide is
retained) is in the cytosol followed by the remaining 135 amino
acid residues of the soluble N-terminal domain residing inside the
ER, and ultimately the lysosome. The short 8 amino acid (Arg628-
Ile635) carboxy-terminal (C-terminal) domain faces the cytosol
(consistent with the survival of various C-terminal epitope tags
after lysosomal compartmentalization [4,5,6,13]). The predicted
relative molecular mass (Mr) including the 30 amino acids of the
signal peptide, is 70.5 kDa (72.6 kDa with our C-terminal
His8Flag tag, Fig. 1A). There are also 5 consensus sites for Asn-
linked glycosylation. Based on topology predictions we obtained
through the TMHMM Server v.2.0, all of these Asn-X-Ser/Thr
sites would be present in the lumen of the ER and thus available
for glycosylation [4] (Fig. 1A). In general when SDS-PAGE is used
to estimate the relative Mr of multi-TMD proteins, the results have
been reported to vary as much as 645% from those predicted
from the deduced primary structures. This is believed to be caused
by variations in the number of SDS molecules bound by the
TMDs in comparison to the numbers bound by the similarly sized
soluble proteins used as standards [15]. Additionally the presence
of Asn-linked oligosaccharides can cause further deviations from
the predicted Mr.
Whereas the deduced C-terminal half of N-acetyltransferase (exons
7–18) is highly conserved across species, including plants and bacteria;
the N-terminus, extending back from the first TMD after the signal
peptide, is only found in metazoans. Neither of these regions display
any sequence homology with other previously identified functional
domains, including those from proteins known to bind CoA or acetyl-
CoA. Thus, the HGSNAT-encoded N-acetyltransferase represents the
human member of a new family of enzymes [4].
N-acetyltransferase has proven very difficult to purify, partly because
of its hydrophobicity, but primarily because its activity appears to be
dependent on protein concentration, i.e., activity is eventually lost as the
purity of the preparation increases [8]. However, based on [
14C]acetyl-
CoA labeling experiments (which are equivocal, because they assume
the formation of E9, see above), the enzyme has been reported to be a
dimer of 120 kDa subunits containing Asn-linked oligosaccharides [8].
The 120 kDa subunit has also been postulated to be only the catalytic
subunit of a protein complex whose other unidentified members are
also needed for functionality [8]. After cloning of the cDNA encoding
the transferase, several groups introduced various C-terminal epitope
tags as a means of studying the biosynthesis and structure of the
enzyme. These tags were shown not to interfere with the intracellular
transport or function of the transferase. Multiple bands with varying
intensities, corresponding to 120 and 75 kDa [6],or77, 67and 48 kDa
[16], were detected by Western blot utilizing antibodies directed at the
C-terminal epitope tag. The 77 kDa band was first reported as
representing the monomer of the active transferase, while the 48 kDa
band was thought likely to be a lysosomal degradation product [16].
However, a more recent publication by the same group reported that
the protein associated with the 48 kDa band and another protein,
associated with a new 29 kDa band (lacking the C-terminal tag),
formed the true subunit of the active transferase oligomer, while the
Figure 1. Scaled diagrams of the full length N-acetyltransferase and the small N-terminal loop fragment of the protein expressed
by the cDNA constructs used in this study. Each construct also encodes a C-terminal His8-Flag tag. Predicted masses (kDa) are shown for each
protein segment. TMDs are indicated by hatched rectangles, soluble loops that are predicted to reside in the ER/lysosomal lumen are shown as clear
boxes and those predicted to reside in the cytosol as shaded boxes. Putative Asn-linked glycosylation sites (NXS/T) are shown as ‘‘*’’. The location and
ends of the peptide sequence used to generate the ‘‘N-terminal’’ antibody and utilized in this report, are shown between the two panels. (A) Full
length N-acetyltransferase with both the long signal peptide (SP-L), found in the genomic sequence [13], and the short signal peptide (SP-S), used in
this report and found in EST data bases are indicated. The positions and sequences of previously published intracellular transport signals [13] are
shown, as are the N-termini, identified in this report, of the processed alpha- and ß- chains. (B) The N-terminal fragment containing the short signal
peptide and the first luminal loop of N-acetyltransferase are depicted.
doi:10.1371/journal.pone.0024951.g001
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inactive precursor polypeptide [13]. This group also initially estimated
the size of the native oligomer at 240 kDa [8], but more recently places
it at 440 kDa [13].
In this report we optimize the detergent extraction and basic
biochemical transferase assay procedures so that the specific activity
of N-acetyltransferase does not vary with protein concentration and
a fully active enzyme can be purified for analyses. We demonstrate
that various amounts of severalirreversible aggregates (.70 kDa on
Western blots) of this hydrophobic protein can form depending on
the method of extraction used prior to SDS-PAGE, or even when
the purified protein, in the presence of nonionic detergent, is briefly
incubatedat 37uC. We re-examine the mechanismand effects ofco-
(endoplasmic reticulum (ER)) and post- (lysosomal) translational
processing of N-acetyltransferase on its intracellular transport and
expression of enzyme activity, and determine the native molecular
weight of the functional enzyme. Finally using our optimized assay
with the purified N-acetyltransferase we re-examine the enzyme’s
kineticmechanismofaction.Ourdata leadtoconclusionsthatdiffer
substantially from those recently published from a similar study of
the enzyme by Durand et al. [13].
Material and Methods
Construction of mammalian expression vectors
containing either the human full-length or a soluble
N-terminal fragment (Met1-Asn163) of the human
N-acetyltransferase, both with an epitope tag
(His8 & Flag) in C-terminal position
The genomic sequence of HGSNAT contains two potential
translation initiation sites differing by 84 bp. Although both have a
consensus Kozak sequence, ESTs covering the full-length cDNA
are only present for the second site (NCBI reference sequence:
NM_152419.2, NP_689632.2). Thus, all cDNA constructs ex-
pressing human N-acetyltransferase used in this report used the
second start site (short form), except when nucleotides encoding a
myc-tag were added to the 59 end (see below).
The full-length human N-acetyltransferase cDNA was previously
sub-cloned in pCMVsport6 (Invitrogen) [4]. This construct was used as
template for amplification by PCR with the following primers 59-
CACCGCAGCGGGCAGGCAAG-39 and 59-GATTTTCCAAA-
AAATCTTCTTTCTATAGAGGATGTAGGCAATGAG-39.T h e
product was then inserted into the mammalian expression vector
pcDNA3.1D/V5-His-TOPOH (Invitrogen) in frame with the V5-
epitope tag. The fidelity of the cloned cDNA was confirmed by
sequencing.
The pcDNA3.1D/V5-His-TOPOH construct was next used as
template by GenScript (Piscataway, NJ, USA) to generate two of
the three constructs used in the present report. First, a full-length
human N-acetyltransferase cDNA with a His8Flag tag in C-
terminal position (pcDNA - N-acetyltransferase-His8Flag) was
constructed by inserting a sequence encoding eight His and the
flag peptide (DYKDDDDK) after Ile635 (at nucleotide sequence
C1905) followed by a stop codon. Second a shorter construct
encoding the short signal peptide, the first luminal loop of N-
acetyltransferase, Met1-Asn163 (Fig. 1B) and a His8Flag epitope
tag downstream from C489 (Asn163) followed by a stop codon
(pcDNA - N-term N-acetyltransferase-His8Flag) was similarly
generated. The two constructs were verified by DNA sequencing.
Addition of a myc epitope tag in N-terminal position of
the pcDNA-N-acetyltransferase-His8Flag construct
Generation of the N-terminally tagged myc-N-acetyltransferase-
His8Flag construct was accomplished by adding nucleotides
encoding the tag to the previous construct (pcDNA-N-acetyltrans-
ferase-His8Flag) through a two steps PCR reaction. The following
two forward primers were sequentially used
59-AAACTCATCTCTGAAGAAGATCTGATGAGCGGGGC-
GGGCA-39 and 59-CCAAGCTTGCCGCCATGGAGCAGAA-
ACTCATCTCTGAAGAAGATCTGATGAGC-39,w i t ht h es a m e
reverse primer 59-CCTCGTGGCCGACATATACCAGAAT-39.
The PCR reactions were performed using HotStar HiFidelity DNA
Polymerase (Qiagen) and the following conditions: denaturation (94uC,
15 sec), annealing (57uC, 1 min), and extension (72uC, 2 min) for 35
cycles with a final extension step at 72uCf o r1 0m i n .T h e nt h eP C R
fragment encoding the N-terminal myc tag was digested with HindIII
and EcoRI, purified and ligated into the pcDNA- N-Acetyltransferase-
His8Flag construct (previously digested with the same restriction
enzymes). The insert was verified by DNA sequencing.
Transient and stable expression of the different human
N-acetyltransferase constructs
HeLa cells (from American Type Culture Collection) were
grown in alpha–MEM medium supplemented with 10% fetal
bovine serum (v/v) (both from Wisent Inc.) and 5% antibiotics
(penicillin, streptomycin from Gibco BRL) at 37uC in a 5% CO2
humidified incubator. HeLa cells were previously assayed for their
endogenous N-acetyltransferase activity, which was found to be
very low (,3 nmol/h*mg).
Transfections using Lipofectamine 2000 (Invitrogen) were
performed at ,90 to 95% confluency following the manufac-
turer’s instructions. These ‘‘transiently’’ transfected cells were
used between 20 and 24 h post-transfection or further
processed for selection of stable clones (i.e., ‘‘permanently’’
transfected cells). Selection of HeLa cell clones permanently
expressing N-acetyltransferase-His8Flag was done after a three
weeks culture period in presence of Geneticin (G418, 400 mg/
ml, Invitrogen) started at 24 h post-tranfection. The remaining
clones were tested for their enzyme activity and the clone
expressing the highest N-acetyltransferase activity was main-
tained in presence of 400 mg/ml of G418 or kept in liquid
nitrogen for further use.
Extraction of N-acetyltransferase in presence of 1%
n-dodecyl ß-D maltoside (DDM extract)
HeLa cells (including cells transfected with the different
constructs, and non transfected control cells) were harvested
and resuspended in phosphate buffer saline (Wisent Inc.)
containing 1% of protease inhibitor cocktail (Sigma-Aldrich)
and freeze-thawed 6 times. The soluble fraction (lysate) was
discarded after centrifugation (100,000 g for 30 min at 4uC) in a
benchtop ultracentrifuge (Beckman Coulter). The membrane
pellet was resuspended in TBS buffer (Tris-HCl 50 mM, NaCl
150 mM, pH 7.4) containing 1% DDM (w/v) and protease
inhibitor cocktail. After homogenization the membrane suspen-
sion was rotated overnight at 4uC to extract membrane proteins.
The next day the DDM-extract was centrifuged again as above
and the resulting supernatant was termed, the DDM or detergent
extract.
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optimum lipid composition and concentration to use in
the transferase assay
Anionic and neutral liposomes were prepared essentially as
previously described [17] with the modifications reported by
Tropak et al. [18]. Briefly, liposomes with different lipid
composition were obtained by mixing cholesterol from Sigma-
Aldrich (CH, 20 mol%), phosphatidyl choline from the same
supplier (PC, 80, 60, or 40 mol%), and phosphatidyl inositol from
Avanti Polar Lipid (PI, 0, 20 or 40 mol%) in chloroform, and then
dried under a stream of nitrogen gas so that upon rehydration a
final lipid concentration of 64 mM could be achieved. The lipid
mixture thus obtained was rehydrated in CP buffer (pH 5.5) and
then freeze-thawed 10 times using a dry-ice/ethanol bath to
ensure solute equilibration between bulk and trapped solutions.
After rehydration the 64 mM lipids stocks were serially diluted
with CP buffer (pH 5.5), such that 2.5 ml of the needed lipid
mixture could be added to N-acetyltransferase assay and produce
the desired final lipid concentration.
Optimization of the enzymatic assay for the
determination of N-acetyltransferase activity
We optimized the methodology previously reported by Voznyi
Ya et al. [11] to measure the N-acetyltransferase activity by using
the following protocol. A master mix was prepared such that
27.5 mL (1 reaction volume) of the mix contained 10 mL of Acetyl-
CoA 6 mM (Sigma-Aldrich), 10 mL of Mu-GlcNH2 3m M
(Moscerdam Substrates) in CP buffer (pH 5.5) with 0.25% Triton
X-100 (v/v), 5 mL Hex (equivalent to 100 nmol/h of total hex
activity, from a human placenta ConA fraction [19]) and 2.5 mLo f
16 mM liposomes (20% PI lipids, see above). Aliquots (27.5 mL)
weredistributed in96wellplatesand 2.5 mLofthedetergentextract
(see above) or purified sample (see below) of N-acetyltransferase was
added to each well to start the enzymatic reaction. The reactions
were performed in duplicate or triplicate at 37uC for 15 min-3 h.
The time of incubation was adjusted to obtain meaningful
fluorescence readings relative to the level of enzyme present. The
reactionswerestoppedbyadditionof2-amino-2-methyl-1-propanol
0.1 M, pH 10.8 (MAP, 200 mL). Fluorescence of the 4-methylum-
belliferone liberated (MU) was measured with a Gemini EM
Microplate Spectrofluorimeter (Molecular Devices Inc.) with the
excitation and emission wavelengths set at 365 and 450 nm
respectively, and analyzed using the SoftMax Pro Software (USA)
coupled to the spectrofluorimeter. Protein concentrations were
measured using Pierce BCA (bicinchoninic acid) Protein Assays
(Thermo Scientific). Quantification of duplicate assays was obtained
from bovine serum albumin (BSA) standard curves according to
manufacturer’s protocol. Specific activities were calculated from the
fluorescence of a MU standard solution and expressed as nmol/
h*mg of total protein in the sample.
The following variations in the above protocol allowed us to
study the effect of, a) the presence or absence of lipid on the
linearity of the N-acetyltransferase assay, b) the composition and
concentration of the liposomes added in the reaction, and c) either
the protein or lipid environment on the stability of the transferase
activity. The effect of added lipid or protein (HSA) on the linearity
of the transferase activity was tested by measuring the transferase
activity of a DDM extract serially diluted and added to 27.5 mLo f
master mix which contained either CP buffer pH 5.5, buffer plus
0.25% human serum albumin (HSA) or buffer plus liposomes
(20% PI). The effect of liposomes composition and/or concentra-
tion on the transferase activity was tested by adding liposomes of
different lipid composition at different concentration in the assay
using equal amounts of purified N-acetyltransferase. Finally to
study the stability of the transferase activity as a function of its
protein or lipid environment, an identical amount of affinity
purified transferase was mixed with equal volume of either CP
buffer (pH 5.5) with 0.25% HSA or 16 mM 20% PI liposomes,
and incubated at 37uC. Samples were taken at various time points
(0–2.5 h) and placed at 4uC. The transferase activity was then
measured in triplicate for each time points using the optimized
assay conditions (including lipids). An aliquot of each time point
was also analyzed by Western blot using the N-terminal antibody.
Purification of N-acetyltransferase by affinity
chromatography
Cell pellets collected from 16 large tissue culture plates of HeLa
cells stably expressing N-acetyltransferase, were used to prepare a
large amount of DDM extract (see above). Further purification of
the DDM extract was performed by affinity chromatography with
mouse anti-Flag M2 affinity gel (beads) (Sigma-Aldrich). The
concentration of DDM in the extract was reduced from 1% to
0.2% by addition of TBS (plus protease inhibitor cocktail) and
then mixed with 80 mL of the anti-Flag M2 affinity gel (Sigma-
Aldrich) suspended in TBS plus 0.2% DDM and incubated
overnight on a rocking platform at 4uC. The beads with bound N-
acetyltransferase protein were collected in a disposable column
(Poly-Prep chromatography column 0.864 cm, Gibco BRL). The
unbound fraction was collected and non-specifically bound
proteins were removed by washing the column with 10 mL of
washing buffer (0.02% DDM in TBS). Finally the purified protein
was eluted with 150 ng/mL FLAG peptide (Sigma-Aldrich) in TBS
plus 0.2% DDM, and 250 mL fractions were collected. The
fractions were immediately tested for transferase activity and
protein concentration. The fractions displaying the highest
transferase specific activity were either used immediately (kinetics
experiments or Western blots) or stored at 220uC.
Cell Lines and tissue Culture Conditions
Primary skin fibroblasts derived from patients with I-Cell or
MPS IIIC (homozygous for a mutation the prevents proper
mRNA splicing [4]) disease, or an unaffected individual (used as a
wild-type (WT) control) were provided by the Hospital for Sick
Children Tissue Culture Facility and were grown in alpha–MEM
medium supplemented with 10% fetal bovine serum (v/v) (both
from Wisent Inc.) and 5% antibiotics (penicillin, streptomycin
from Gibco BRL) at 37uC in a 5% CO2 humidified incubator.
Western blots
The different subunits corresponding to the N-acetyltransferase
protein were detected by Western blot analysis. Samples were
diluted in 46Laemmli sample buffer (Tris-HCl 62.5 mM pH 6.8,
2% SDS (w/v), 5% ß-mercaptoethanol (v/v), 10% glycerol (v/v)
and 0.002% bromophenol blue (w/v)), incubated at room
temperature (RT) overnight and resolved by SDS-PAGE using
Nu-PAGE 4–12% Bis-Tris gel (Invitrogen). Then proteins were
electrophoretically transferred to polyvinylidene fluoride (PVDF)
membranes (BioRad), which were then blocked with 5% (w/v)
non-fat dry milk in TBST (Tris-HCl 25 mM, pH 7.4, NaCl
137 mM, KCl 2.7 mM and 0.1% Tween-20 (v/v)) overnight at
4uC. After incubation with primary (90 min at RT) and secondary
antibodies (1 h at RT), signals were generated using enhanced
chemiluminescence (ECL and ECL Advanced western blotting
detection, Amersham GE Healthcare). The following primary
antibodies were used: rabbit polyclonal IgG anti-DYKDDDDK
(i.e., Flag) Tag and anti-EEA1 (an early endosomal marker) from
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Calnexin (an ER marker) from Santa Cruz Biotechnology at 1/
200; mouse monoclonal Flag M2 IgG from Sigma-Aldrich at the
same dilution; rabbit polyclonal HGSNAT IgG (raised against
peptide corresponding to Q52 to N156 of N-acetyltransferase
protein) from Sigma-Aldrich at 1/1500; mouse monoclonal myc
IgG (clone 4A6) from Millipore at 1/1000; rabbit polyclonal Hex
A IgG at 1/400 and rabbit polyclonal cation-independent
mannose phosphate receptor IgG at 1/1000 dilution, the last 2
antibodies were produced in our laboratory. The secondary
antibody used were either HRP-conjugated donkey anti-rabbit,
donkey anti-goat (Jackson Immunology) or goat anti-mouse at
1:10,000 dilution (Santa Cruz). Samples were analyzed by Western
blot were processed as indicated above, unless otherwise noted in
the figure legend.
SYPRO Ruby staining
Protein concentration of affinity purified N-acetyltransferase
was estimated using SYPRO Ruby methodology from Molecular
Probes (Invitrogen) to eliminate the interference of the Flag
peptides used to elute the enzyme. In short, a sample of purified N-
acetyltransferase was separated by SDS-PAGE on a Nu-PAGE 4–
12% Bis-Tris gel (Invitrogen) in parallel with increasing amounts
of BSA (0–800 ng). After fixation in a methanol (50%) - acetic acid
solution (7%) for 15 min at RT, the gel was stained using the
SYPRO Ruby protein gel stain solution for 30 min (including
3630 sec microwave period) and washed with a methanol (10%) -
acetic acid (7%) solution for 30 min at RT. The luminescence of
SYPRO ruby was recorded using a phosphorimager (Molecular
Dynamics, Storm 840 with ImageQuant software) and the pixel
intensities corresponding to the sum of the 2 luminescent bands
observed for BSA was plotted against their concentrations to
generate a standard curve. The protein concentration in the N-
acetyltransferase sample was calculated from the sum of the pixel
intensities measured from the 3 major luminescent bands observed
on the gel migrating at 62, 44 and 27 kDa respectively.
Edman-Amino acid sequencing
Amino acid sequencing was performed by the Advanced Protein
Technology Center at the Hospital for Sick Children (http://www.
sickkids.ca/Research/APTC/Edman-Sequencing/index.html). In
short, purified N-acetyltransferase blotted onto PVDF membrane
was excised and treated with phenylisothiocyanate. The produced
cleavable phenylthiohydantoin amino acid derivatives were sub-
jected to N-terminal sequencing by Edman degradation using
Procise 490 Protein Sequencer, the Model 140 C Microgradient
Delivery System. Data quantitation and protein sequencing
reporting was generated using Procise control software and the
Model 610A Data Analysis software.
Purification of iron-dextran-filled lysosomes by magnetic
chromatography (FeDex)
N-acetyltransferase transfected HeLa cells were grown in
presence of paramagnetic iron colloidal particles for 9 hours
[20]. After several washes cells were gently homogenized and post-
nuclear supernatant (PNS) collected at 2,000 rpm at 4uC. An
enriched lysosomal fraction was obtained by magnetic separation
of iron-dextran-loaded lysosomes from the PNS by using MACS
separation columns (Miltenyi Biotec) as previously described [21].
Endo H and PNGase treatment
The glycosylation state of N-acetyltransferase-His8Flag from
stably transfected Hela cells was analyzed by using purified
lysosomal fractions (above). The glycosylation state of myc-N-
acetyltransferase-His8Flag from transiently transfected Hela cells
was analyzed using a DDM extract (as described above). And
finally the glycosylation state of N-term N-acetyltransferase-
His8Flag was analyzed using the soluble fraction obtain after
freezing-thawing cell pellet (lysate) from HeLa cells transiently
transfected with the N-terminal construct. The different samples
were incubated in the presence or absence of Endo H
endoglycosidase and PNGase glycopeptidase (New England
BioLabs) according to the manufacturer’s protocol. Denaturation
of the full-length glycoproteins was performed at 37uC for 2 hours
or for the soluble N-terminal fragment, by boiling. EndoH or
PNGase was then added and the deglycosylation reaction carried
out at 37uC for either 4 hours, for the N-acetyltransferase protein
because of its TMDs, or only 2.5 hours for the N-terminal
fragment. Treated and control samples were subjected to Western
blot analysis as described above using antibodies as indicated in
figure legend.
Immunoprecipitation
DDM extracts from HeLa cells transiently transfected with the
myc-N-acetyltransferase-His8Flag construct or permanently trans-
fected with the control N-acetyltransferase-His8Flag construct
were diluted to 0.2% DDM, and myc mouse monoclonal IgG
added. The reactions were gently mixed for 1 h at 4uC followed by
the addition of 50 mL of 50% slurry of washed GammaBind Plus
Sepharose (GE Healthcare) (protein G beads). The mixtures were
rotated overnight at 4uC. The N-acetyltransferase activities
immobilized on the Sepharose beads and that remained in
unbound fractions were measured separately after a centrifugation
and washing steps (as above).
Indirect immunofluorescence staining and confocal
microscopy imaging
Indirect immunolabeling was performed using a previously
described protocol [22] using transiently transfected HeLa cells at
20 h post transfection with either pcDNA-N-acetyltransferase-
His8Flag, pcDNA-N Term N-acetyltransferase-His8Flag or
pcDNA-myc-N-acetyltransferase-His8Flag construct (untrans-
fected cells represent ‘‘in situ’’ controls).
Primary antibodies were as follows: Mouse Flag (M2) IgG and
human glucocerebrosidase rabbit polyclonal IgG [21], or a N-
terminal N-acetyltransferase rabbit polyclonal and a protein
disulfide isomerase (PDI) mouse monoclonal IgG (Stressgen).
Secondary antibodies were chicken anti-mouse Alexa fluor 488
(green) for flag and goat anti-rabbit Alexa fluor 594 (red) for
glucocerebrosidase or chicken anti-rabbit Alexa 488 (green) for the
N-terminal of N-acetyltransferase and goat anti-mouse Alexa 594
(red) for PDI (Molecular Probes) at a 1:200 dilution in blocking
solution. Samples were analyzed using a Zeiss Axiovert confocal
laser microscope equipped with a 6361.4 numerical aperture
Apochromat objective (Zeiss) and LSM 510 software. DAPI-
stained nuclei were detected on the same system with a
Chameleon two-photon laser. Confocal images were imported
and contrast/brightness adjusted using Volocity 5 program
(Improvision Inc.).
Native size exclusion chromatography column
DDM extracts (,600 mL) from 2 large tissue culture plates of N-
acetyltransferase transfected HeLa cells were prepared as above.
The resulting membrane extract (,500 mL) was then loaded onto
a Sephacryl S-400 HR column (total column volume 153 mL,
Pharmacia Biotech) with TBS plus DDM 0.02% as mobile phase.
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proteins as molecular weight standard thyroglobulin (669 kDa),
alcohol dehydrogenase (150 kDa), bovine serum albumin
(66 kDa), ovalbumin (45 kDa) and carbonic anhydrase (29 kDa),
and blue dextran and sodium azide were used as markers for void
volume and total volume respectively (all from Sigma-Aldrich).
Elution was performed under gravity at 4uC with 1 mL fractions
collection. Each fraction was assayed for N-acetyltransferase
activity (aliquots of 2.5 mL as described above). Protein concen-
tration for each fraction was also determined and every other
fraction between elution the volume of 70 mL to 160 mL were
analyzed by dot blot (only every 5 fraction is shown under the
graph). An aliquot (6 mL, 362 mL) was applied onto a nitrocel-
lulose membrane (Protran BA 85, Whatman) and processed
similarly to a western blot (see above) using polyclonal rabbit N-
terminal N-acetyltransferase IgG as the primary antibody.
Kinetic analyses
Kinetic analyses were performed using the optimized N-
acetyltransferase assay with freshly affinity purified transferase.
Because the concentrations of the 2 substrates were varied between
the different kinetics experiments, a slightly different protocol was
used for the transferase assay. Instead of preparing a master mix
with all of the reagents then adding the transferase as indicated
earlier, we prepared a mix containing multiples of fixed amount of
purified transferase (2.5 mL), liposomes (2.5 mL) and Hex (5 mL),
corresponding to 10 mL per reaction, and then added the 2
substrates separately allowing us a great flexibility in their
respective concentration.
To generate the Michaelis-Menten and Lineweaver-Burk plots
either the final concentration of the substrate Mu-GlcNH2 ranged
between 0.01 to 1 mM while the Acetyl-CoA concentration was
kept fixed at 0.17, 0.33 or 1.0 mM, or the final concentration of
Acetyl-CoA ranged from 0.0833 to 2 mM while the Mu-GlcNH2
concentration was kept fixed at 0.05, 0.10 or 0.30 mM.
To determine the kinetic parameters, the concentration of MU-
GlcNH2 ranged between 0.01 and 0.5 mM while the Acetyl-CoA
concentration was constant at 2 mM (saturating). Or the
concentration of Acetyl-CoA ranged between 0.0833 and 2 mM
while MU-GlcNH2 was constant at 1 mM (saturating). The values
of the kinetic parameters (Km and Vmax) were extracted via
nonlinear regression analysis using Prism 5.0 (Graph Pad
Software. Inc., USA). Kcat were then separately calculated from
the respective Vmax. The standard errors were calculated from
the best-fit curves generated by the computer program.
Determining if a acetylated protein intermediate (E9)i s
formed when purified N-acetyltransferase is incubated
with [
3H]acetyl-CoA
DDM extracts were prepared from 2 large tissue culture plates
of N-acetyltransferase permanently transfected and untransfected
(control) HeLa cells. The same amount of protein from both
samples was diluted with TBS to achieve a final concentration of
0.2% for DDM. After addition of 40 mL of pre-equilibrated (in
TBS plus DDM 0.2%) anti-flag M2 affinity gel suspension, the
samples were rotated overnight at 4uC. The following day, the
beads were washed 3 times with TBS plus DDM 0.02%, and
incubated with 0.6 mCi of [
3H] acetyl-CoA (2.5 Ci/mmol, Perkin
Elmer) in CP buffer either at pH 6.5 or pH 6.8 containing 0.1%
DDM, in presence or in absence of liposomes (20% PI, final
concentration 1.33 mM) at RT for 1 or 0.5 h, respectively. After
centrifugation and three washes with TBS plus 0.02% DDM, the
beads and unbound fraction (including the washes) were collected
separately and their radioactivity measured by liquid scintillation.
Three independent experiments for stably N-acetyltransferase
transfected and HeLa control were performed. Using the same
experimental conditions another set of experiments was performed
in which [
3H] acetyl-CoA was omitted to allow for the
determination of the amount of N-acetyltransferase activity that
was immobilized.
Results
Classic extraction with Triton X-100 [6,11,23,24] of N-
acetyltransferase from a HeLa cell line, established from a clonal
population of cells permanently transfected with the enzyme
containing a 2.1 kDa C-terminal-His8Flag tag (Fig. 1A), was
compared to extractions with other detergents. It was found that
the transferase specific activity in 0.1% or 1% Triton, or in 0.1%
NP-40 extracts was 130–170 nmol/h*mg. On the other hand
extraction with 1% n-dodecyl ß-D maltoside (DDM) resulted in a
specific activity of 530 nmol/h*mg. The transferase activity in the
DDM-extract also remained stable for at least 6 months at -20uC.
We investigated the linearity of the classic fluorescent-based,
coupled transferase assay [11,24] using N-acetyltransferase
transfected HeLa cells extracted with DDM. The activity dropped
precipitously with little activity remaining after the total extracted
protein concentration was reduced from 0.65 to 0.33 mg/mL, even
when 0.25% BSA (w/v) was included in the dilution buffer
(Fig. 2A). Since in vivo the N-acetyltransferase resides in the highly
negatively charged environment of the lysosomal membrane, we
investigated the possibility that its transferase activity was
dependent on the presence of negatively charged lipids, rather
than other unidentified proteins, as previously suggested [8]. N-
acetyltransferase, purified on anti-Flag beads, was assayed in the
presence of neutral or anionic liposomes, prepared and used
essentially as was done for GM2 ganglioside assays with the GM2
Activator protein and ß-hexosaminidase (Hex) A [17]. An
increasing negative charge was obtained by increasing the content
of PI with a commensurate decrease in the level of neutral PC.
The addition of negatively charged lipids to the assay resulted in a
dramatic increase in N-acetyltransferase activity with the optimal
activity observed with either 1.3 mM of lipid containing 20 or
40% PI, or 0.67 mM containing 40% PI (Fig. 2B). A comparison
of the stability of the purified enzyme at 37uC in CP pH 5.5,
containing 0.1% DDM and either HSA (0.25%, w/v) or lipid
(1.3 mM, 20% PI) demonstrated that the presence of lipids also
greatly enhanced the enzymes resistance to heat inactivation
(Fig. 2C). These data demonstrate that in the absence of lipids the
purified protein loses ,50% of its transferase activity after only
0.5 h at 37uC. The addition of the lipid mixture to the buffer used
to dilute the original DDM extract from transfected HeLa cells
also preserved the linearity of the transferase reaction below total
protein levels of 0.6 mg/mL (Fig. 2A). The reaction remained linear
for at least 3 h (data not shown). Levels of Hex needed in the
coupled reaction were also evaluated. It was determined that 100
units (nmol MUG/h) of Hex per assay were sufficient to ensure
linearity even at very high levels of transferase activity (data not
shown).
Many proteins with multiple TMDs denature during and after
extraction by forming irreversible aggregates. Extracting and
heating samples in SDS prior to PAGE can also enhance the
formation of these aggregates [25]. Thus we examined the effects
on the banding pattern produced from reduced samples on
Western blots (visualized with a Flag antibody) using N-
acetyltransferase extracted from transfected HeLa cells. We
compared our method of first extracting with 1% DDM then
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RT (Fig. 3, lane 1), with other previously published methods.
These included homogenized, sonicated, and then boiled in
lithium dodecyl sulfate reducing sample buffer (Invitrogen) [13]
(Fig. 3, lane 2) or extracted with 2% SDS followed by dilution with
SDS-PAGE reducing sample buffer and heating at 65uC [6] (Fig. 3,
lane 3). Whereas the method used in this report, initial DDM
extraction, produced the highest yield of unaggregated N-
acetyltransferase, direct extraction with 2% SDS primarily
produced irreversible aggregates. The major aggregate had an
apparent Mr of 77 kDa followed by a secondary aggregate band at
120 kDa (Fig. 3, lane 3). Thus we concluded that after SDS-PAGE
any bands observed for our N-acetyltransferase construct, with its
small 2.1 kDa epitope tag (Fig. 1A) .70 kDa represent aggregates.
N-acetyltransferase was purified from 16615 cm plates of
transfected HeLa cells using an anti-Flag affinity column, eluted
with Flag peptides. The components of the purified protein
preparation were separated under reducing conditions by SDS-
PAGE and visualized using SYPRO Ruby protein gel stain. Two
dominant bands at 62 kDa and 44 kDa, also seen on Western
blots of the DDM extract (Fig. 3), plus a light band at 27 kDa
(Fig. 4A) were detected. Western blots of the purified protein,
Figure 2. Effects of lipids on N-acetyltransferase activity are
illustrated. Each set of data points represents the average of triplicate
determinations of N-acetyltransferase activity with their standard
deviations (SD) shown as error bars (A) DDM extracts from permanently
transfected HeLa cells were serially diluted in CP buffer, pH 5.5 (filled
diamonds), CP buffer containing 0.25% HSA (filled squares) or CP buffer
containing 1.3 mM 20% PI (filled circles with the error bars representing
SD too small to see, connected by the best fit line, R=1) (X-axis, total
extracted protein; Y-axis, transferase activity in nmol/h). (B) Equal
amounts of anti-Flag-column purified N-acetyltransferase were assayed
in the presence of increasing concentrations of lipids (X-axis, mM) with
decreasing mole% of negatively charged PI (40-0% PI+40–80% PC+20%
CH); 40% PI, darkly shaded bars; 20% PI, grey hatched bars; or PC (0%
PI), white bars. (C) Stability of identical amounts of purified N-
acetyltransferase in CP buffer pH 5.5, containing either 0.25% (w/v)
HSA (white bars) or 1.3 mM, 20% PI, lipids (shaded bars) (X-axis, hours at
37uC; Y-axis transferase activity in nmol/h).
doi:10.1371/journal.pone.0024951.g002
Figure 3. The effects of detergent extraction procedures on the
intensity of bands associated with monomeric N-acetyltrans-
ferase (i.e., 62 and 44 kDa), detected by Western blotting with
the C-terminal rabbit Flag antibody. HeLa cells, permanently
transfected with N-acetyltransferase-His8Flag, were; lane 1- first
extracted with 1% DDM, centrifuged and the extract denatured in
SDS-PAGE sample buffer (containing a reducing agent) at room
temperature; lane 2- homogenized (in water), sonicated and boiled in
lithium dodecyl sulfate reducing sample buffer [13]; or lane 3- extracted
with 2% SDS, diluted with SDS-PAGE reducing sample buffer and
heated at 65uC [6]. Bottom panel shows the loading control, the cation-
independent mannose-6-phosphate receptor, which contains a single
TMD.
doi:10.1371/journal.pone.0024951.g003
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available antibody made against residues 53–156 (Fig. 1) of N-
acetyltransferase (N-terminal antibody), were compared to the
protein stain (Fig. 4B). Both antibodies detected the 62 kDa band.
The 44 kDa band was strongly recognized by the C-terminal and
weakly by the N-terminal antibody. The 27 kDa band was
strongly recognized only by the N-terminal antibody. These data
suggest that the larger band corresponds to the full length
polypeptide and that the 27 and 44 kDa bands correspond to the
N-terminal and C-terminal portions of the 62 kDa precursor
polypeptide, respectively, generated by a posttranslational proteo-
lytic event(s). Interestingly the ratio of intensities of these bands
varied not only as a function of the antibody used, but also with
the sample preparation method. For example t‘he 62 kDa band
was more intense when the N-terminal antibody was used and the
protein was directly eluted from the Flag column using SDS
sample buffer (Fig. 4B lane 2), rather than first being eluted with
Flag peptides and then denatured in SDS sample buffer (Fig. 4B
lane 1). While in the former case aggregate bands were not
detectable, in the latter case two aggregate bands at 77 kDa
(major) and 120 kDa were clearly visible. On the other hand with
the N-terminal antibody, the crude cell extract produced the most
intense 27 kDa band and a very weak 44 kDa band (Fig 4B, left
panel, lane ‘‘Ex’’). These variations may result from differences in
the antibody accessibility to the associated protein-epitope. It also
follows that the small 27 kDa protein is poorly stained by the
SYPRO Ruby protein stain as compared to the proteins associated
with the 62 or 44 kDa bands (Fig. 4A). The effects on the banding
patterns produced by Western blots utilizing the N-terminal
antibody were investigated after incubation of the purified enzyme
in the absence of added lipids at 37uC over time (0–2.5 h). The
resulting Western blot demonstrated that along with a rapid loss of
activity (Fig. 2C) there is also a time dependent increase in the
levels of irreversible aggregate bands, particularly the 77 and
120 kDa species (Fig. 4C).
The final specific activity of the affinity purified N-acetyltrans-
ferase in the presence of lipid was estimated at 260 mmol MU/
h*mg with a yield of ,50% and an enrichment of ,500-fold over
the DDM-extract. Because of the presence of the Flag peptides
used to elute N-acetyltransferase-His8Flag, protein concentration
was estimated from the relative fluorescence units of the Ruby
stained gel, using a dilution series of bovine albumin as a protein
standard (Fig. 4A, BSA). Importantly, these data indicate that the
protein encoded by the HGSNAT gene alone is sufficient to
produce N-acetyltransferase activity, i.e., N-acetyltransferase is not
a multimer of two or more subunits encoded by different genes as
has been previously suggested [8].
The mature amino-termini of the N-acetyltransferase alpha-
and ß-polypeptides were determined by Edman degradation of the
proteins contained within the excised bands from the above gel
(Fig. 4A). The amino terminal sequence obtained from the alpha-
chain was KKRHAE48 and from the ß-chain, GVSEIA150
(Fig. 1A). These data are consistent with the specificity of the two
antibodies used in the Western blots (12 N-terminal residues of the
ß-chain were part of the peptide epitope used to generate the N-
terminal antibody). Edman degradation analysis of the 62 kDa
band failed to produce any sequence data, suggesting the presence
of a blocked amino terminus. Mass spectrometry analysis of the
tryptic peptides generated from the 62 kDa band demonstrated
the presence of peptides predicted to be part of both the alpha-
and ß-chains, consistent with its recognition by both antibodies
and indicative of it being the N-acetyltransferase precursor
polypeptide. However no peptides were identified that corre-
sponded to the predicted signal peptide (data not shown).
Since the new commercially available N-terminal antibody
offered us the opportunity to probe the structure of endogenous N-
acetyltransferase in human fibroblast, we confirmed the presence
of the 62 kDa precursor and 27 kDa processed alpha-chain (the
alpha-chain from human fibroblast migrates at an apparent Mr of
29 kDa) in normal and I-cell patient fibroblasts, and confirmed the
lack of these bands in an extract from a MPS IIIC patient’s cells
(Fig. 5) homozygous for a mutation that prevents normal mRNA
splicing [4]. I-cell disease fibroblasts lack GlcNAc-1-phospho-
Figure 4. Purification of N-acetyltransferase by anti-Flag
affinity chromatography. (A) Lane 1- SDS-PAGE separation of the
purified enzyme under reducing conditions detected with fluorescent
SYPRO Ruby protein stain. Also shown is a dilution series of BSA used to
calculate the protein levels in the transferase sample and the specific
activity of the purified enzyme; and (B) Western blotting using either an
antibody against the Gln53-Asn156 epitope (N-term), or against the C-
terminal Flag tag (Flag). Lane-1 contains the transferase that was
bound, eluted with Flag peptides and then denatured, while lane 2
contains enzyme that was directly released and denatured from the
anti-Flag column with SDS sample buffer (containing a reducing agent).
Aliquots of the initial 1% DDM extract (Ex) were also examined by
Western blotting. Bands marked ‘‘X’’ in the Ex lanes are non-specific
proteins detected by the antibodies (the ,30 kDa X band is only seen
with the rabbit Flag antibody). (C) The effects of incubating the purified
protein at 37uC for 0–2.5 h without added lipids were examined by
Western blotting using the N-terminal antibody.
doi:10.1371/journal.pone.0024951.g004
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proteases with mannose-6-phasphate residues [26,27], which are
required for targeting them to the lysosome via the mannose-6-
phosphate receptor [28]. Despite being deficient in many soluble
proteases no increase in the levels of the 62 kDa band versus the
processed 27 (29) kDa band was seen, nor was the specific activity
of N-acetyltransferase significantly decreased (Fig. 5). The 44 kDa
band was also detected, but required much longer exposure times,
causing the 62 and 27 (29) kDa bands to be severely over-exposed
(data not shown).
The suspected lysosomal cellular location for processing of the
precursor chain was confirmed by magnetic fractionation of N-
acetyltransferase from transfected cells loaded with iron dextran
particles (FeDex method) [29]. Cell homogenates were separated
into a post-nuclear-supernatant (PNS) and an enriched lysosomal
(Lys) fraction, and equal amounts of total protein (1 mg) were
analyzed by Western blotting (Fig. 6). A Western blot for N-
acetyltransferase-His8Flag protein was produced using the N-
terminal N-acetyltransferase antibody (Fig. 6, N-term). Much
larger amounts of the precursor form of N-acetyltransferase was
detected in the lysosomal (Lys), as compared to the PNS fraction of
cells. However the processed 44 kDa ß-and 27 kDa alpha- chains
were only detected in the Lys fraction. An unidentified
contaminant band at ,50 kDa (also seen in Fig. 4B) was also
detected in the PNS fraction (Fig. 6, X). As a positive control for
the enrichment of lysosomes in the Lys-fraction, the blot was
stripped and re-probed with an IgG against the lysosomal marker
Hex A (Fig. 6, Hex A). The expected 53 (alpha-subunit) and
29 kDa (ß-subunit) bands corresponding to the processed mature
forms of the Hex A subunits were only detected in the Lys fraction
[30]. The two ,61 kDa alpha- and ß- precursor chains were
weakly detected in both fractions [30]. Reprobing of the blot with
IgG against the ER marker calnexin and the early endosomal
marker EEA1 demonstrated that these proteins were concentrated
in the PNS fraction of cells (Fig. 6, bottom). These results indicate
that the single 62 kDa N-acetyltransferase precursor chain is
efficiently transported to the late endosome/lysosome after
synthesis where it is processed into its mature alpha- and ß-chains.
The oligosaccharide structures of the proteins contained in the
three major bands associated with N-acetyltransferase in the above
lysosomal enriched fraction (free of the confounding ,50 kDa
nonspecific band, Fig. 6 ‘‘X’’) were examined as substrates for
endoglycosidase H (endo-H) and/or glycopeptidase-F (PNGase)
digestions (Fig. 7A & B). The 62 kDa precursor band contained
both endo-H sensitive (high mannose type) and insensitive
(complex type) oligosaccharides. The N-terminal alpha-chain,
predicted to have 3 potential glycosylation sites (Fig. 1), also
contained both types of oligosaccharides (Fig. 7A), while the ß-
chain, predicted to have 2 potential glycosylation sites (Fig. 1)
contained only complex types (Fig. 7B). Furthermore, the Mr
calculated from the gel of the mature, deglycosylated alpha-chain
was 12 kDa (Fig. 7A), which is nearly identical to the 11.7 kDa
predicted for residues Lys43-Asn144 from N-acetyltransferase, and
significantly different from the 16 kDa predicted for the alpha-
chain retaining the signal peptide (Fig. 1A).
The N-acetyltransferase precursor protein has previously been
reported to be inactive and to have retained its signal peptide [13].
This would result in the signal peptide becoming the first of 12
permanent TMDs. However, it is clear from the N-terminal
sequence (13 residues C-terminal to the predicted signal peptide
cleavage site (Fig. 1A)) and the observed Mr of the deglycosylated
alpha-chain (Fig. 7A) that if the signal peptide was not cleaved co-
translationally by the signal peptidase in the ER, then it would be
removed postranslationally during the lysosomal maturation of N-
acetyltransferase, resulting in a protein with 11 TMDs.
Figure 5. Western blot analysis of the endogenous N-acetyl-
transferase protein in three human fibroblast cell lines.
Fibroblast from an unaffected individual (WT), a patient with I-Cell
disease, and a MPS IIIC patient were extracted with 1% DDM, 20 mg
each of extracted protein were separated by SDS-PAGE, and the N-
acetyltransferase proteins visualized using the N-terminal antibody. The
blot was reprobed with anti GAPDH as a loading control. The specific
activity of each extract is shown at the bottom, ND is not detected.
doi:10.1371/journal.pone.0024951.g005
Figure 6. Western blot analysis of the post nuclear supernatant
(PNS) and enriched lysosomal (Lys) fractions separated
magnetically from extracts of N-acetyltransferase-His8Flag
permanently transfected HeLa cells loaded with iron-dextran
(FeDex). After SDS-PAGE the proteins in the PNS and Lys fractions
(1 mg total protein from each fraction was loaded) were visualized with
the N-terminal N-acetyltransferase antibody (N-term). The nonspecific
,50 kDa band visualized with the N-terminal antibody is marked as
‘‘X’’. As control for the enrichment of lysosomes in the ‘‘Lys’’ fraction,
the blot was stripped and re-probed with an antibody against human
lysosomal ß-hexosaminidase A (Hex A). Furthermore, markers for the ER
(Calnexin) and early endosome (EEA1) were visualized after stripping
and re-probing the blot with the appropriate antibody (bottom).
doi:10.1371/journal.pone.0024951.g006
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acetyltransferase precursor, a construct encoding a myc-tagged
extension (10 residues) to the N-terminus of the signal peptide, was
transiently expressed in HeLa cells. Western blot analysis
comparing this doubly tagged protein with singly-tagged N-
acetyltransferase-His8Flag (using the N-terminal antibody) re-
vealed the presence of a single major band (Fig. 8A lane 2)
corresponding to a slightly higher Mr than the singly-tagged
62 kDa precursor (Fig. 8A, lane 1). Significantly, no band
corresponding to the processed alpha-chain was detected in the
myc-N-acetyltransferase-His8Flag sample (lane 2). The specific
transferase activities of the cell extracts were also determined, with
untransfected HeLa cell extract containing 3 nmol/h*mg of
endogenous activity. The extract from the permanently transfected
cells containing the singly-tagged protein was ,4-fold greater
(540 nmol/h*mg) than the cell extract containing the transiently
expressed doubly tagged N-acetyltransferase (150 nmol/h*mg).
This difference is consistent with the levels of N-acetyltransferase
cross-reacting material detected on the Western blot (Fig. 8A).
These data demonstrate that despite a lack of processing, the
doubly-tagged protein is fully active. This conclusion was further
confirmed after immuno-precipitation of extracts from the two cell
lines with myc IgG immobilized on Protein-G beads. The
immobilized transferase activity from the doubly-tagged (+myc)
protein extract was 12 nmol/h, as compared to 0.7 nmol/h for
the singly-tagged (-myc) protein extract. These data also
demonstrate that the extended myc-tagged signal peptide is
retained in the active doubly-tagged precursor protein. Next the
oligosaccharide structures on the myc-N-acetyltransferase-His8-
Flag were examined and found to be fully endo-H sensitive, i.e., it
contained only high mannose type oligosaccharides, indicating an
ER localization (Fig. 8B). Indirect immunofluorescence and
confocal microscopy imaging were used to compare the cellular
localization of the singly- (Fig. 9A) and doubly- (Fig. 9B & C)
tagged N-acetyltransferase proteins using the Flag or N-terminal
antibody. The protein with only the C-terminal tag co-localized
with the lysosomal marker ß-glucocerebrosidase (Fig. 9A), while
the doubly tagged protein did not (Fig. 9B), again consistent with
an ER-localization. This was confirmed by using an IgG against
the ER marker PDI, which co-localized with the doubly- tagged
enzyme (Fig. 9C). These data suggest that the retention of the
signal peptide prevents intracellular transport of the precursor to
the lysosome and proteolytic processing into the mature alpha-
and ß- chains, but does not prevent it from expressing transferase
activity.
In order to determine if the wild-type signal peptide was co-
translationally cleaved, an N-acetyltransferase N-terminal con-
struct, encoding residues 1–163-His8-Flag (stopping 2 residues
short of the first TMD, Fig. 1B), was made and transiently
expressed in HeLa cells. This protein should lack all signals for
lysosomal incorporation. The resulting protein (without oligosac-
Figure 7. Western blot analyses of the N-acetyltransferase-
His8Flag protein from the ‘‘Lys’’ fraction of Figure 6 (lane 1)
treated with either endo-H (lane 2) or PNGase (lane 3). Proteins
were detected with either, (A) the N-terminal N-acetyltransferase
antibody or (B) the Flag M2 antibody.
doi:10.1371/journal.pone.0024951.g007
Figure 8. The protein expressed by a construct encoding myc-
N-acetyltransferase-His8Flag was analyzed by Western blot-
ting. (A) Extracts from HeLa cells permanently expressing the singly-
tagged N-acetyltransferase-His8Flag (lane 1) were compared with HeLa
cell transiently expressing myc-N-acetyltransferase-His8Flag (lane 2)
using the N-terminal N-acetyltransferase antibody. The levels of
transferase activity in the extracts are given below each lane. (B) The
oligosaccharides present on the doubly-tagged myc-N-acetyltransfer-
ase-His8Flag protein (lane 1) were analyzed based on endo-H (lane 2)
and/or PNGase (lane 3) sensitivities by Western blotting using a myc
antibody.
doi:10.1371/journal.pone.0024951.g008
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forms of N-acetyltransferase. (A) N-acetyltransferase-His8Flag, (B & C) myc-N-acetyltransferase-His8Flag, or (D & E) the N-terminal segment (Met1-
Asn163-His8Flag) of N-acetyltransferase (Fig. 1). Cells were stained with the mouse M2 Flag antibody (green A, B & D) and a rabbit antibody against
either a lysosomal marker, glucocerebrosidase (red, A, B & D), or against the N-terminus of N-acetyltransferase (green) and a mouse antibody against a
ER marker, PDI (red, C & E), and the images merged. Scale bars represent 10 mm. Images shown are representative of 10 recorded.
doi:10.1371/journal.pone.0024951.g009
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without the signal peptide (Fig. 1B). The protein was not secreted,
but it was detected, along with other soluble enzymes, in the
detergent-free lysate of the transfected cells. This observation
suggests that the protein is retained in the ER, but without its
signal peptide, which would have acted as a TMD. Immunoflu-
orescence images confirmed that the N-terminal fragment was not
located in the lysosome (Fig. 9D), but in the ER (Fig. 9E). The
protein was analyzed by Western blotting with the N-terminal
antibody. A single band was detected with a Mr of 34 kDa (Fig. 10,
lane 2). Significantly, the fragment was also found to contain only
endo-H sensitive oligosaccharides, consistent with an ER locali-
zation, and after deglycosylation it was associated with a 17 kDa
band (Fig. 10. lanes 1 & 3). From these data we conclude that the
signal peptide is co-translationally cleaved in both the N-terminal
fragment and in full length N-acetyltransferase.
The native apparent Mr of N-acetyltransferase was determined
by molecular size exclusion chromatography on a 9061.5 cm
Sephacryl S-400 column eluted at 4uC. The transferase activity
eluted as a single peak with a shoulder on the high Mr side of the
curve. The estimated Mr of the protein at the peak of its activity
was 80 kDa (Fig. 11). Dot blots with the N-terminal antibody
showed that no detectable inactive N-acetyltransferase protein was
eluted in any other fractions. These data indicate that N-
acetyltransferase functions as a monomer.
The kinetics of the transferase reaction were re-examined using
the optimized assay procedure and the affinity purified N-
acetyltransferase protein. First, three fixed amounts of either
acetyl-CoA (Fig. 12A, 0.17, 0.33 or 1.0 mM) or MU-GlcNH2
(Fig. 12B, 0.05, 0.10 or 0.30 mM) were assayed with increasing
concentrations of the other substrate and directly fitted to the
Michaelis-Menten equation (Fig. 12). These data were then used
to construct the double-reciprocal plots according to Lineweaver
and Burk (Fig. 12A & B, insets). The resulting best-fit lines were
not parallel, which would have indicated a ping-pong mechanism,
but intersecting. Thus, in agreement with Meikle et al. [14], these
data strongly suggest a random sequential mechanism, with the
formation of a ternary complex [31], rather than the previously
reported ping-pong double displacement mechanism. Similarly,
the Km, Vmax and kcat of N-acetyltransferase were calculated
from the Michaelis-Menten equation with each substrate fixed in
turn at a saturating level, i.e., AcCoA at 2 mM or Mu-GlcNH2 at
1 mM, and the other substrate varied as in Figure 12 (Table 1).
Since two groups have published data supporting the formation
of an acetylated-N-acetyltransferase intermediate using radiola-
beled acetyl-CoA [8,9,12,13], and thus a ping-pong reaction
mechanism, an attempt was made to detect such a labeled
intermediate utilizing N-acetyltransferase-His8Flag immobilized
on the anti-Flag column. The column immobilized ,300 nmol/h
of transferase activity, or ,1 mg of purified N-acetyltransferase-
His8Flag protein, from extracts obtained from two 15 cm plates of
transfected HeLa cells. Based on the specific activity of the
[
3H]acetyl-CoA that was used and a molar ratio of 1:1 binding,
,6,000 cpm more should have bound to the N-acetyltransferase
immobilized on beads, than to control beads treated with a similar
amount of untransfected HeLa cell extract. Table 2 demonstrates
that there was no measurable increase in the levels of [
3H] bound
on the beads containing the immobilized N-acetyltransferase.
These results are consistent with the previous conclusion made
from the kinetic data (Fig. 12), i.e., that a ping-pong mechanism is
not used and that no acetylated-N-acetyltransferase intermediate is
formed during the enzyme reaction.
Discussion
In this report we characterize the co- and post-translational
processing of N-acetyltransferase and their effects on structure and
function of the enzyme. We also document the kinetic mechanism
used by N-acetyltransferase, employing our optimized assay
procedure, which includes negatively charged lipids in the reaction
mix. Recently Durand et al. published the results of a similar study
[13]. They concluded that; a) N-acetyltransferase is synthesized as
an inactive precursor of 77 kDa, which contains an uncleavable
signal peptide as its first TMD; b) the precursor is transported to
the lysosome through conventional Tyr- and diLeu-based signals
in its C-terminal cytosolic tail, with some contribution made by a
second diLeu signal in a cytosolic loop near the N-terminus
(Fig. 1A); c) in the lysosome the precursor is converted into a
29 kDa N-terminal alpha- and a 48 kDa ß-chain held together by
Figure 10. The degree of endo-H versus PNGase sensitivities
was used to probe the level of Asn-linked oligosaccharide
processing that occurs on the N-terminal fragment (Met1-
Asn163-His8Flag) of N-acetyltransferase (Fig. 1) from tran-
siently expressing HeLa cells. Proteins from soluble cell lysates (i.e.,
not detergent extracts) were analyzed by Western blotting using the N-
terminal antibody.
doi:10.1371/journal.pone.0024951.g010
Figure 11. Proteins extracted from HeLa cells permanently
expressing N-acetyltransferase-His8Flag were separated by
molecular size exclusion chromatography on a 9061.5 cm
Sephacryl S-400 column eluted at 46C. Each 1 mL fraction (X-axis)
was analyzed for transferase activity (nmol/mL* h, left Y-axis, solid line)
and total protein (mg/mL, right Y-axis, dashed line). Additionally every
fifth fraction was analyzed for N-acetyltransferase protein by dot-blot
using the N-terminal antibody (shown below the X-axis).
doi:10.1371/journal.pone.0024951.g011
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assembled into active ,440 kDa oligomers; and e) acting through
a ping-pong mechanism, an acetylated protein intermediate is
formed from acetyl-CoA at His269 in the active site of N-
acetyltransferase. Some aspects of conclusions a), c) and d)
contradict conclusions that this group has made in previous
publications [8,16]. In this report we confirm and expand on
conclusion c), and present strong evidence against a), d) and e). We
also dispute conclusion b) based on more theoretical grounds
coupled with our demonstration that the N-acetyltransferase
precursor is active.
Many of the discrepancies in the numbers and apparent Mr of
bands seen in Western blots of N-acetyltransferase [6,8,13,32] can
be explained by the tendency of multi TMD proteins to form
irreversible (even with SDS) aggregates as they denature, due to
heating or even an extended stay at 37uC in non-ionic detergents
(Fig. 4C). This tendency can be exacerbated if the protein is
extracted with certain detergents and particularly if directly
extracted with 2% SDS (Fig. 3, lane3) (e.g., [6]), even without
heating [25]. We demonstrate that for our construct, which
encodes the enzyme with a small epitope tag (Fig. 1A), bands seen
on Western blots above ,70 kDa represent irreversible aggregates
and have no biological relevance (Figs. 3 & 4).
It has been shown that the apparent monomeric Mr, as
determined by SDS-PAGE, of protein containing multiple TMDs,
such as N-acetyltransferase, can vary as much as 645% from that
predicted from its deduced primary sequence, because of
variability in the binding of SDS molecules by the TMDs [15].
Additionally the presence of oligosaccharide can increase the
apparent Mr, and the N-acetyltransferase precursor chain has 5
consensus Asn-linked glycosylation sites. In the lysosome the
precursor is converted to its small alpha- chain (Lys43-Asn144),
with 3 glycosylation sites, and ß- chain (Gly145-Ile635), with 2 sites
(Figs. 1A & 6). The data presented here are consistent with all 5
sites being occupied (Fig. 7A & B), and with the predicted 11
TMDs, which dictate the orientation of the joining loop structures,
i.e., with loops 1, 7 and 11 (carrying the glycosylation sites) residing
in the lumen of the ER (Fig. 1A). We demonstrate that
deglycosylation of the precursor chain (containing both complex
and high mannose oligosaccharides) decreases its apparent Mr
from 62 to 50 kDa (predicted Mr, 73 kDa with or 70 kDa without
the signal peptide), the C-terminal mature ß-chain (containing all
11 TMD and only complex oligosaccharides) from 44 to 38 kDa
(predicted Mr, 57 kDa) (Fig. 7B) and the alpha-chain (containing
no TMD and both complex and high mannose oligosaccharides)
from 27 to 12 kDa (predicted Mr, 16 kDa with and 12 kDa
without the signal peptide) (Fig. 7A).
Using the N-terminal antibody and extracts from non-
transfected human fibroblasts, we also demonstrated that the
conversion of the single 62 kDa precursor into smaller alpha- and
ß-chains is not an artifact of over expressing an epitope tag N-
acetyltransferase protein (Fig. 5). Interestingly, there was no
significant difference in the ratio of the precursor to the processed
forms of the protein between normal fibroblasts and cells from a
patient with I-cell disease. Nor was there any significant difference
in the specific activity of the enzyme between these cell lines. Since
I-cells fibroblasts are deficient in multiple soluble proteases [28],
that depend on a mannose-6-phosphate tag [27] for transport to
the lysosome (e.g., Cathepsin B, D, F, H, K, L, O, S and Z [26]),
processing must occur through an as yet unidentified protease(s).
Additionally these data confirm that N-acetyltransferase is not
dependent on the mannose-6-phosphate receptor for transport to
the lysosome (Fig. 5).
Some of the variations in apparent Mr reported here and those
previously published [13] can be explained by the large C-terminal
epitope tag, 7.8 kDa, used by Durand et al., compared to our
Figure 12. Direct Michaelis-Menten best-fit curves of specific
activity (nmol/h*ng) versus [S] for the N-acetyltransferase
reaction with graphic insets displaying the corresponding
Lineweaver-Burk double reciprocal plots. Anti-flag affinity column
purified N-acetyltransferase was used and each datum point represents
the average of two or three assays. (A) The concentration of MU-GlcNH2
was varied between 0.01 and 1 mM, while AcCoA was fixed at 0.17 mM
(m), 0.33 mM(#) or 1.0 mM (&). (B) The concentration of AcCoA was
varied between 0.083 and 2.0 mM while MU-GlcNH2 was fixed at
0.05 mM (X), 0.10 mM (%) or 0.30 mM (N). The experiment was
independently repeated three times with a representative set of
graphics shown.
doi:10.1371/journal.pone.0024951.g012
Table 1. Kinetic parameters of the N-acetyltransferase-
His8Flag.
Substrate Km (mM) Vmax (nmol/h/ng) kcat (S
21)
MU-GlcNH2
1 0.4560.09 0.5460.06 10.3861.14
Acetyl-CoA
2 0.5060.02 0.3860.01 7.3360.10
1Concentrations were varied between 0.01 and 0.5 mM while the AcCoA
concentration was fixed at 2 mM.
2Concentrations were varied between 0.083 and 2 mM while the MU-GlcNH2
concentration was fixed at 1 mM.
doi:10.1371/journal.pone.0024951.t001
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apparent Mr of the glycosylated ß-chain, containing the epitope
tags, and the smaller 2 kDa difference in the Mr we report for the
glycosylated alpha-chain, lacking the tag, but does not explain the
15 kDa difference observed in the Mr of the precursor chain
(discussed below).
The amino-terminal sequence of the alpha-chain coupled with
the observations that, a) it appears on Western blots as a single
band, i.e., there is no larger form that could potentially include the
signal peptide with a blocked N-terminus and b) its deglycosylated
Mr is identical to that predicted for a peptide composed of Lys43-
Asn144 (Fig. 1A), indicate that it does not contain the signal
peptide and thus has no TMD. Therefore, either the signal peptide
is cleaved co-translationally in the ER or is removed in the
lysosome prior to the proteolytic event that produces the alpha-
and ß- chains (Fig. 6). To try and differentiate between these two
possibilities we attached a ten amino acid myc-tag to the amino-
terminus of the signal peptide. The tag did not interfere with
translocation of the nascent peptide into the ER, as judged by the
presence of high mannose oligosaccharides on the protein (Fig. 8B).
However, the tagged protein was unable to exit the ER for
processing in the lysosome into the alpha- and ß- chains (Figs. 8A
& 9C). Similarly, it has been reported that the addition of an N-
terminal GFP-tag to the ordinarily cleavable signal peptide of
glucagon-like peptide-1 receptor, prevented signal peptide cleav-
age and transport of the receptor out of the ER to the plasma
membrane [33]. These data suggest that for some proteins, an N-
terminal extension of their signal peptides interferes with signal
peptide cleavage, which in turn prevents the proteins from exiting
the ER. Significantly the ER localized precursor polypeptide
containing the N-terminal myc extension expressed near normal
levels of N-acetyltransferase activity (Fig. 8A), which could be
immobilized on Protein-G beads containing a myc IgG. These
data clearly demonstrate that the precursor is active and does not,
as previously reported [13], need to be proteolytically processed
and assembled into oligomers or multienzyme complexes in the
lysosome to become functional.
Many lysosomal proteins undergo posttranslational proteolytic
processing in the late endosome/lysosome, which can include both
endo- and exo-proteolytic fragmentation. However, in only a few
cases does the fragmentation process involve the activation of a
zymogen. Usually such cases involve a lysosomal protease, e.g.
cathesin D, and likely represent a cellular protective mechanism.
On the other hand, many glycosidases undergo multiple
proteolytic processing events that lead to no observable biochem-
ical changes in their function (reviewed in [34]), e.g. the alpha- and
ß-subunits of Hex A [30]. The proteolytic processing of the Hex A
subunits produce several active intermediate forms with different
pIs, originally thought to be unique Hex isozymes. These event
have been characterized by pulse chase experiments in human
fibroblasts [35,36] and by Edman degradation of isolated
‘‘intermediate isozyme forms’’ from human placenta [37]. These
events represent the digestion of surface loop structures once they
have been exposed to the lysosomal environment [38,39]. Such
loops were likely only needed during protein folding and disulfide
bond formation in the ER.
In order to differentiate between the co- or post-translational
removal of the signal peptide, an N-terminal construct containing
the signal peptide and most of the N-terminal luminal loop
structure (Fig. 1B) was expressed in HeLa cells. The expressed
protein was soluble, but remained in the ER (Fig. 9D & E). The
protein was also fully deglycosylated by endo-H digestion (Fig. 10),
resulting in an apparent Mr nearly identical to that predicted for
the protein devoid of the 2.6 kDa signal peptide, i.e., 17 kDa
(Figs. 1B & 10). From these and data from the N-terminal myc
construct, we conclude that the signal peptide is cleaved co-
translationally and that this event is necessary for transport of full
length N-acetyltransferase out of the ER, but not for folding into a
functional precursor enzyme.
There are two possible translational start sites predicted from
the genomic sequence of N-acetyltransferase, one encodes a 58
residue ‘‘long’’ signal peptide (Fig. 1A, SP-L) and the other a 30
residue ‘‘short’’ peptide (Fig. 1A, SP-S) [13]. The short sequence is
the only one found in a spliced EST data base and was thus used
by ourselves [4] and other [6] as the initiating ATG in our N-
acetyltransferase cDNA expression constructs (the amino acid
numbering used here assumes this ATG encodes Met1). The
group represented by Feldhammer et al. [16] and Durand et al.
[13] primarily used the long sequence, containing both ATGs, to
express N-acetyltransferase and conclude that the long signal
peptide is retained in the enzyme. However, our data clearly
demonstrates that the mature alpha-chain does not contain the
short signal peptide. Thus, assuming that the long signal peptide
was not removed co-translationally in the ER we would expect to
Table 2. Immobilized [3H]acetylated N-acetyltransferase-His8Flag intermediate cannot be detected in immunoprecipitation
experiments with anti-Flag M2 beads.
With lipids
1 at pH 6.5, 60 min Immobilized on Flag-Beads Unbound & washes
Total cpm Activity
2 Total cpm Activity
Transfected
1 1,230
3 640 232 (13) 87,30062,100 1.2
Untransfected
1 1,240 660 1.1 85,00062,100 ND
4
Without lipids
1 pH 6.8, 30 min Immobilized on Flag-Beads Unbound & washes
Total cpm Activity Total cpm Activity
Transfected 1,150 6150 278 (15.5) 88,00065,500 0.6
Untransfected 1,210 6140 0.3 92,00064,000 ND
1Anti-Flag beads were incubated with extracts from HeLa cell expressing (Transfected) or not expressing (Untransfected) N-acetyltransferase-His8Flag, washed and then
incubated with [3H]acetyl-CoA for the given time and pH, at room temperature and with or without 1.3 mM of lipids containing 20% PI.
2N-acetyltransferase activity in nmoles of MU produced/hour, and the concentration of protein (pmoles), calculated based on the specific activity of the purified
transferase, are given.
3The data represent three independent beads binding experiments and assays.
4Not detectable.
doi:10.1371/journal.pone.0024951.t002
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Durand et al. [13]. Depending on whether the initial cleavage
occurred at Lys43 or Gly145, a decrease of 6.7 kDa (the Mr of the
sequence between the first ATG of the long signal peptide and
Lys43 (Fig. 1A)) in either the precursor or the mature alpha-chain
should have been observed. However, their data failed to show
such a decrease during the chase period in either protein band
[13]. While the apparent Mr they report for the mature alpha-
chain is only 2 kDa larger than the 27 kDa we report, their
precursor chain is ,15 kDa heavier (77 versus 62 kDa). Whereas
the 2 kDa difference is insignificant, the ,15 kDa is not, even
taking into account their ,6 kDa larger C-terminal tag. However,
if the signal peptide was to be removed when protein initiation
occurs at the second ATG (short), allowing transport to the
lysosome for processing, but was retained if the first ATG (long)
was used, preventing transport out of ER (similar to the effects we
observe after adding the myc tag to the short signal peptide), this
would increase the Mr by an additional 5.4 kDa, which would
result in an insignificant ,4 kDa difference. For this explanation
to be correct protein initiation would have to occur at both the first
and second ATGs in their expression construct. This is
theoretically possible as the group synthesized the extension and
part of the short signal peptide in order to make their expression
construct and reportedly included a HindIII restriction site directly
upstream of the first initiating ATG, i.e., AAGCTTATGA in their
long signal peptide. They also convert the sequence downstream of
the second initiating ATG site from the wild-type GGCATGA,
which is used in this work, to GGCATGT [5]. Importantly, the
addition of the HindIII site results in the generation of a very poor
Kozak consensus sequence at the first ATG site. The optimum
sequence for initiation by eukaryotic ribosomes is ACCATGG
with a purine (A/G) in the dominant -3 position. If the first ATG
is present in a weak Kozac sequence it may be skipped and
translation can begin at a down stream ATG with a stronger
sequence [40]. When a pyrimidine replaces the purine in the -3
position, translation also becomes more sensitive to changes in
positions -1, -2, and +4 [40]. Previously reported experimental
data also support this hypothesis. Feldhammer et al. reported that
their 77 kDa precursor band was reduced to 67 kDa when treated
with either endo-H or PNGase, indicating that it contained only
high mannose oligosaccharides, consistent with the majority of the
protein being localized in the ER. However, consistent with our
data for the mature ß-chain (Fig. 6B), they also reported the
presence of a weak 48 kDa band containing only complex
oligosaccharides [16]. The 62 kDa N-acetyltransferase precursor
protein we expressed with the short signal peptide contained both
high mannose and complex carbohydrates (Fig. 7A & B) and was
found primarily in lysosomes (Figs. 6 & 9A). An N-acetyltransfer-
ase precursor protein containing fully endo-H sensitive oligosac-
charides was only seen when the myc N-terminal tag was added
(Fig. 8B). This protein was not transported to the lysosome
(Fig. 9B), but retained in the ER (Fig. 9C). Furthermore, no myc-
alpha-chain was detected with the myc-antibody (Fig. 8B), nor was
any mature alpha-chain detected with the N-terminal antibody
(Fig. 8A). During the generation of the myc-N-acetyltransferase
construct, the sequence surrounding our original ATG, initiating
the short signal peptide, was replaced by CTGATGA (a weak
Kozac sequence) and the new initiating site for the myc extension
was GCCATGG, consistent with translation primarily occurring
at this upstream site [40].
A putative YXXØ lysosomal targeting motif, where Ø is a large
hydrophobic residue and X is any amino acid, was identified by
Durand et al., LIAYILY627 (Fig. 1A), as residing in the C-
terminal tail of N-acetyltransferase [13]. However, for several
reasons we believe that this putative signal sequence is unlikely to
be functional. Firstly, this sequence motif has a statistical
probability of appearing in many proteins, but for it to be
functional it must also be accessible for interacting with the
components of the cell’s sorting machinery, i.e., it must not be
folded into the structure of the protein [41]. However, this putative
N-acetyltransferase transport signal is predicted by Durand et al.
[13], Feldhammer et al. [16] and ourselves [4] (using the
TMHMM Server v.2.0) to comprise the C-terminal section of
the final TMD (residues 608–627) of N-acetyltransferase (Fig. 1A).
For lysosomal-sorting, these types of signal are located 6–9
residues from the final TMD [41]. Secondly, although X-X can be
‘‘any amino acids’’, hydrophilic amino acids are favored and for
lysosomal-sorting, acidic residues are generally found in the X
positions, as is an important Gly preceding the critical Tyr (Y)
residue. Thirdly, another Tyr residue has not been reported in the
Ø position of any other functional targeting sequence [41].
Fourthly, Durand et al. mutated their putative critical Tyr
(Y624A) and the protein was still processed, which should have
eliminated this as a targeting motif [41]. It was only when the
entire C-terminal sequence was deleted (del 624–635) that N-
acetyltransferase failed to be processed or produced any
transferase activity. This large deletion is predicted by the
TMHMM Server to destabilize the final TMD, resulting in the
C-terminus of N-acetyltransferase-del 624–635 residing in the
lumen of the ER, i.e., the protein is likely misfolded. Finally, an
important control for the use of in vitro mutagenesis as a means to
identify transport signals is that the resulting protein retains its
functionality. Since Durand et al. mistakenly identified the N-
acetyltransferase precursor as inactive, this important control was
not considered. Indeed re-evaluation of their data suggests the true
signal for intracellular transport is likely the ETDRLI209 sequence
that they identified in the first large cytosolic loop of N-
acetyltransferase (Fig. 1A). This fits the majority of criteria for
one of the two classes of di-Leu repeat signals, [DE]XXXL[LI],
which does not need to be present in the C-terminal tail in order to
function [41]. Durand et al. reported that mutations of the critical
Leu and/or Ile resulted in little N-acetyltransferase processing and
near normal transferase activity [13].
Although we agree that the N-acetyltransferase precursor is
cleaved in the lysosome into mature alpha- and ß- chains, Durand
et al. estimated that the cleavage occurred within the end of the
first and/or beginning of the second lysosomal loop, based on
tryptic fragments identified by mass spectrometry [13]. The
amino-terminal sequencing reported here directly places the
mature amino terminus of both the alpha- (Lys43) and ß-
(Gly145) chains within the first intra-lysosomal loop of N-
acetyltransferase (Fig. 1A). Additionally, the weak cross-reactivity
of the ß-chain with the N-terminal antibody (Figs. 4, 5, 6, 7), made
against residues 53–156, is consistent with cleavage in the first
lysosomal loop not the second (Fig. 1A).
We examined the native Mr of N-acetyltransferase by
conventional standing molecular sieve chromatography with
Sephacryl S-400. To prevent aggregation the separation was
carried out at 4uC and the elution buffer contained 0.02% DDM.
The resulting calculated Mr of 80 kDa indicates that N-
acetyltransferase functions as a monomer (Fig. 11). Additionally
since N-acetyltransferase, purified on a Flag antibody column, is
fully functional (in the presence of negatively charged lipids, Fig. 2)
and protein stained SDS-PAGE gels show only band that are also
detected by either the Flag or the N-terminal N-acetyltransferase
antibodies (Fig. 4), we conclude that the protein encoded by the
HGSNAT gene is both necessary and sufficient to produce active
N-acetyltransferase in vivo, as well as in vitro.
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acetyltransferase and found, in agreement with Meikle et al. [14],
that it was not a ping-pong double displacement, but a random-
order ternary-complex mechanism (Fig. 12). These data were
confirmed by demonstrating that no [
3H]acetylated-N-acetyltrans-
ferase intermediate was formed using ,1 mg of fully functional,
purified and immobilized N-acetyltransferase (Table 2). Thus,
although we cannot rule out the possibility that His269 is part of
the active site of N-acetyltransferase, our data clearly demonstrate
that its acetylation, as determined by mass spectrometry [13], is
not likely to be biologically relevant.
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